Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.70 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.28 | €100.00 | 48.633% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.63 | €3.70 | 126.994% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.80 | €24.13 | 63.117% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.64 | €4.16 | 153.887% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.22 | €116.81 | 20.148% |
| Cigna Corp. | 17 | 0 | 2 | 0 | €323.35 | €342.35 | 5.876% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €392.60 | €406.87 | 3.634% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €25.14 | 14.291% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €96.00 | €109.94 | 14.525% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €9.96 | €26.95 | 170.688% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €80.49 | €88.14 | 9.501% |
| Patterson Companies Inc. | 7 | 0 | 1 | 0 | €23.60 | €32.18 | 36.365% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.45 | €8.27 | 28.260% |
| Insulet Corp. | 16 | 0 | 3 | 0 | €154.10 | €215.54 | 39.869% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €113.00 | €147.62 | 30.634% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.23 | €8.36 | 158.996% |
| PTC Therapeutics Inc. | 13 | 5 | 2 | 0 | €28.20 | €41.81 | 48.277% |